Screener
AIM ImmunoTech AIM Q4 2025 Annual earnings
Reported March 27, 2026 · Before market open
Revenue$21.0KMiss by $79.0K
EPS-$0.44Beat by $0.50
Revenue estimate$100.0K
EPS estimate-$0.94
Next report
Nov 16, 2026 (in 3 months)Revenue estimate$25.7K
EPS estimate-$0.12
Versus estimates
Revenue
Q2 2026$26.0KMiss by $74.0KQ1 2026$22.0KBeat by $11.0K
Q4 2025$21.0KMiss by $79.0K
Q3 2025$26.0KQ2 2025$25.0KMiss by $75.0KQ1 2025$16.0KDiluted EPS
FAQ
- When did AIM ImmunoTech report Q4 2025 earnings?
- AIM ImmunoTech (AIM) reported Q4 2025 earnings on March 27, 2026 before market open.
- What were AIM ImmunoTech's Q4 2025 revenue and EPS?
- AIM ImmunoTech reported revenue of $21.0K and eps of $-0.44 for Q4 2025.
- Did AIM ImmunoTech beat estimates in Q4 2025?
- Revenue missed the consensus estimate of $100.0K by $79.0K. EPS beat the consensus estimate of $-0.94 by $0.50.
- How did AIM ImmunoTech's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 53.3% from $45.0K a year earlier and eps grew 95.6% from $-10.00.
- Where can I find AIM ImmunoTech's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-013301) directly on SEC EDGAR. The filing index links above go to sec.gov.
